- Home
- DXR vs PGZ Comparison
DXR vs PGZ Comparison
Compare DXR & PGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DXR | PGZ |
|---|---|---|
| Founded | 1970 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.5M | 69.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | DXR | PGZ |
|---|---|---|
| Price | $12.25 | $10.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $25.00 | N/A |
| AVG Volume (30 Days) | 4.3K | ★ 23.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.26% |
| EPS Growth | ★ 3.46 | N/A |
| EPS | ★ 0.36 | N/A |
| Revenue | ★ $66,306.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $33.97 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.55 | $8.46 |
| 52 Week High | $14.15 | $10.59 |
Technical Indicators
Market Signals| Indicator | DXR | PGZ |
|---|---|---|
| Relative Strength Index (RSI) | 40.20 | 38.98 |
| Support Level | $12.11 | $9.97 |
| Resistance Level | $13.02 | $10.16 |
| Average True Range (ATR) | 0.47 | 0.08 |
| MACD | -0.09 | 0.00 |
| Stochastic Oscillator | 6.75 | 30.78 |
Price Performance
Historical ComparisonAbout DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
About PGZ Principal Real Estate Income Fund of Beneficial Interest
Principal Real Estate Income Fund is a non-diversified, closed-end management investment company. Its investment objective is to provide high current income with capital appreciation by investing in commercial real estate-related securities. The company does its investments in USA, Australia, Japan, France, Great Britain, Canada, Hong Kong, Germany, Singapore, South Korea, British Virgin Islands and more.